SOAT1 and uveitis: Consistent with current research, including ongoing clinical trials and documented case reports exploring therapeutic strategies targeting JAK/STAT signaling as a novel treatment approach for both groups of uveitis (Supplementary Table S9), we found a specific but interconnected network of IRGs modulated by IFN types I, II, and III in both uveitis groups (Figure 5A).